Synthetic Design Lab is a clinical-stage biotechnology company founded in 2022 developing next-generation antibody-drug conjugates (ADCs) for cancer therapy. Its SYNTHBODY platform and SYNTHBODY Engine engineer multispecific biologics with layered BIO-LOGIC control mechanisms and targeted payload delivery reported at 10x or more versus… - View it on GitHub